scispace - formally typeset
C

Chris J.L.M. Meijer

Researcher at VU University Amsterdam

Publications -  745
Citations -  83366

Chris J.L.M. Meijer is an academic researcher from VU University Amsterdam. The author has contributed to research in topics: Cervical cancer & Cervical intraepithelial neoplasia. The author has an hindex of 128, co-authored 733 publications receiving 78705 citations. Previous affiliations of Chris J.L.M. Meijer include VU University Medical Center & Academic Center for Dentistry Amsterdam.

Papers
More filters
Journal ArticleDOI

Direct immunosuppressive effects of EBV-encoded latent membrane protein 1.

TL;DR: It is shown that nanogram amounts of purified recombinant LMP1 (rLMP1) strongly suppresses activation of T cells and suggests that EBV-positive tumor cells may actively secrete L MP1 and thus mediate immunosuppressive effects on tumor-infiltrating lymphocytes.
Journal ArticleDOI

Causes of Cervical Cancer in the Philippines: a Case-Control Study

TL;DR: It is shown that HPV is the central cause of adenocarcinoma/adenosquamous carcinoma of the uterine cervix and high parity, low socioeconomic status, and smoking were also associated with both types of cervical cancer.
Journal ArticleDOI

Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells

TL;DR: Significant improvements are reported here in the functional expression of specific human TCRs that will hopefully expedite clinical application of TCR transfer-based immunotherapy.
Journal ArticleDOI

Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.

TL;DR: Most ovarian carcinomas, including the mucinous ones, can be discriminated with high probability from colonic carcinomas using a panel of three antibodies directed against CEA, cytokeratin 7, and vimentin, which appeared to be CK7 and CEA.
Journal ArticleDOI

Intra‐operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer

TL;DR: The results indicate that OSNA‐CK19 can potentially be useful in an intra‐operative clinical setting to detect SN tumor involvement in breast cancer patients.